Cytokines in neuroblastoma: From pathogenesis to treatment

Vito Pistoia, Giovanna Bianchi, Giacomo Borgonovo, Lizzia Raffaghello

Research output: Contribution to journalArticle

Abstract

Cytokines released by cancer cells or by cells of the tumor microenvironment stimulate angiogenesis, act as autocrine or paracrine growth factors for malignant cells, promote tumor cell migration and metastasis or create an immunosuppressive microenvironment. These tumor-promoting effects of cytokines also apply to neuroblastoma (NB), a pediatric neuroectodermal malignancy with frequent metastatic presentation at diagnosis and poor prognosis. IL-6 and VEGF are the best characterized cytokines that stimulated tumor growth and metastasis, while others such as IFN-γ can exert anti-NB activity by inducing tumor cell apoptosis and inhibiting angiogenesis. On the other hand, cytokines are part of the anti-NB therapeutic armamentarium, as exemplified by IL-2 and granulocyte-macrophage colony stimulating factor that potentiate the activity of anti-NB antibodies. These recent results raise hope for more efficacious treatment of this ominous pediatric malignancy.

Original languageEnglish
Pages (from-to)895-907
Number of pages13
JournalImmunotherapy
Volume3
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Neuroblastoma
Cytokines
Neoplasms
Pediatrics
Neoplasm Metastasis
Cellular Microenvironment
Tumor Microenvironment
Granulocyte-Macrophage Colony-Stimulating Factor
Immunosuppressive Agents
Vascular Endothelial Growth Factor A
Cell Movement
Interleukin-2
Anti-Idiotypic Antibodies
Interleukin-6
Intercellular Signaling Peptides and Proteins
Apoptosis
Growth

Keywords

  • chemokine
  • cytokine
  • immunotherapy
  • neuroblastoma

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Cytokines in neuroblastoma : From pathogenesis to treatment. / Pistoia, Vito; Bianchi, Giovanna; Borgonovo, Giacomo; Raffaghello, Lizzia.

In: Immunotherapy, Vol. 3, No. 7, 07.2011, p. 895-907.

Research output: Contribution to journalArticle

Pistoia, Vito ; Bianchi, Giovanna ; Borgonovo, Giacomo ; Raffaghello, Lizzia. / Cytokines in neuroblastoma : From pathogenesis to treatment. In: Immunotherapy. 2011 ; Vol. 3, No. 7. pp. 895-907.
@article{f50b0f26b6954843be116872a1bfdc4c,
title = "Cytokines in neuroblastoma: From pathogenesis to treatment",
abstract = "Cytokines released by cancer cells or by cells of the tumor microenvironment stimulate angiogenesis, act as autocrine or paracrine growth factors for malignant cells, promote tumor cell migration and metastasis or create an immunosuppressive microenvironment. These tumor-promoting effects of cytokines also apply to neuroblastoma (NB), a pediatric neuroectodermal malignancy with frequent metastatic presentation at diagnosis and poor prognosis. IL-6 and VEGF are the best characterized cytokines that stimulated tumor growth and metastasis, while others such as IFN-γ can exert anti-NB activity by inducing tumor cell apoptosis and inhibiting angiogenesis. On the other hand, cytokines are part of the anti-NB therapeutic armamentarium, as exemplified by IL-2 and granulocyte-macrophage colony stimulating factor that potentiate the activity of anti-NB antibodies. These recent results raise hope for more efficacious treatment of this ominous pediatric malignancy.",
keywords = "chemokine, cytokine, immunotherapy, neuroblastoma",
author = "Vito Pistoia and Giovanna Bianchi and Giacomo Borgonovo and Lizzia Raffaghello",
year = "2011",
month = "7",
doi = "10.2217/imt.11.80",
language = "English",
volume = "3",
pages = "895--907",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "Future Medicine Ltd.",
number = "7",

}

TY - JOUR

T1 - Cytokines in neuroblastoma

T2 - From pathogenesis to treatment

AU - Pistoia, Vito

AU - Bianchi, Giovanna

AU - Borgonovo, Giacomo

AU - Raffaghello, Lizzia

PY - 2011/7

Y1 - 2011/7

N2 - Cytokines released by cancer cells or by cells of the tumor microenvironment stimulate angiogenesis, act as autocrine or paracrine growth factors for malignant cells, promote tumor cell migration and metastasis or create an immunosuppressive microenvironment. These tumor-promoting effects of cytokines also apply to neuroblastoma (NB), a pediatric neuroectodermal malignancy with frequent metastatic presentation at diagnosis and poor prognosis. IL-6 and VEGF are the best characterized cytokines that stimulated tumor growth and metastasis, while others such as IFN-γ can exert anti-NB activity by inducing tumor cell apoptosis and inhibiting angiogenesis. On the other hand, cytokines are part of the anti-NB therapeutic armamentarium, as exemplified by IL-2 and granulocyte-macrophage colony stimulating factor that potentiate the activity of anti-NB antibodies. These recent results raise hope for more efficacious treatment of this ominous pediatric malignancy.

AB - Cytokines released by cancer cells or by cells of the tumor microenvironment stimulate angiogenesis, act as autocrine or paracrine growth factors for malignant cells, promote tumor cell migration and metastasis or create an immunosuppressive microenvironment. These tumor-promoting effects of cytokines also apply to neuroblastoma (NB), a pediatric neuroectodermal malignancy with frequent metastatic presentation at diagnosis and poor prognosis. IL-6 and VEGF are the best characterized cytokines that stimulated tumor growth and metastasis, while others such as IFN-γ can exert anti-NB activity by inducing tumor cell apoptosis and inhibiting angiogenesis. On the other hand, cytokines are part of the anti-NB therapeutic armamentarium, as exemplified by IL-2 and granulocyte-macrophage colony stimulating factor that potentiate the activity of anti-NB antibodies. These recent results raise hope for more efficacious treatment of this ominous pediatric malignancy.

KW - chemokine

KW - cytokine

KW - immunotherapy

KW - neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=79960494406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960494406&partnerID=8YFLogxK

U2 - 10.2217/imt.11.80

DO - 10.2217/imt.11.80

M3 - Article

C2 - 21751957

AN - SCOPUS:79960494406

VL - 3

SP - 895

EP - 907

JO - Immunotherapy

JF - Immunotherapy

SN - 1750-743X

IS - 7

ER -